GSUN — Golden Sun Health Technology Balance Sheet
0.000.00%
Last trade - 00:00- $6.70m
- $10.26m
- $10.16m
Annual balance sheet for Golden Sun Health Technology, fiscal year end - September 30th, USD millions except per share, conversion factor applied.
2020 September 30th | 2021 September 30th | 2022 September 30th | 2023 September 30th | 2024 September 30th | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | PROSPECTUS | 20-F | 20-F | 20-F | 20-F |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Cash | |||||
| Cash and Equivalents | |||||
| Cash and Short Term Investments | 3.21 | 1.19 | 20.3 | 6.55 | 0.84 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 0.162 | 1.37 | 0.746 | 0.478 | 0.614 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 5.14 | 5.53 | 22.1 | 12.1 | 10.4 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 11.8 | 0.375 | 0.344 | 1.67 | 0.914 |
| Long Term Investments | |||||
| Other Long Term Assets | |||||
| Total Assets | 17.4 | 6.64 | 23.4 | 19.4 | 17.1 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 19 | 12.6 | 12.6 | 10.8 | 13.6 |
| Long Term Debt | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Minority Interest | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 24.6 | 14.2 | 14.6 | 15 | 16.4 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Other Equity | |||||
| Total Equity | -7.12 | -7.55 | 8.79 | 4.43 | 0.718 |
| Total Liabilities & Shareholders' Equity | 17.4 | 6.64 | 23.4 | 19.4 | 17.1 |
| Total Common Shares Outstanding |